Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “N Meningitidis Serogroup B”

28 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 28 results

Testing effectiveness (Phase 2)Study completedNCT00129116
What this trial is testing

3 Formulations of Hib-MenCY-TT Vaccine & 1 Formulation of Hib-MenC-TT Vaccine Compared to Licensed Meningococcal Serogroup C Conjugate Vaccine, Each Administered at 2,3,4 Mths of Age

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 388
Large-scale testing (Phase 3)Study completedNCT01214850
What this trial is testing

Novartis Vaccine and Diagnostics Carriage Trial

Who this might be right for
N. Meningitidis Carriage
Novartis Vaccines 2,968
Testing effectiveness (Phase 2)Study completedNCT01461993
What this trial is testing

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17

Who this might be right for
VaccinesMeningococcal Vaccines
Pfizer 2,499
Large-scale testing (Phase 3)Study completedNCT01553279
What this trial is testing

Immunogenicity and Safety of V419 (PR51) in Combination With MCC in Infants and Toddlers (V419-011)

Who this might be right for
Neisseria MeningitidisBacterial InfectionsVirus Diseases
MCM Vaccines B.V. 284
Testing effectiveness (Phase 2)Study completedNCT02534935
What this trial is testing

Immunogenicity, Safety and Tolerability of a Neisseria Meningitidis Serogroup B Bivalent Recominant Lipoprotein 2086 Vaccine (Bivalent rLP2086) in Healthy Toddlers.

Who this might be right for
Meningococcal B Disease
Pfizer 396
Testing effectiveness (Phase 2)Study completedNCT01323270
What this trial is testing

A Trial to Assess the Safety, Tolerability and Immunogenicity of Repevax and rLP2086 Vaccine When Given Together in Healthy Subjects Aged >=11 to <19 Years.

Who this might be right for
Meningococcal VaccinerLP2086Repevax+2 more
Pfizer 753
Large-scale testing (Phase 3)Study completedNCT00161928
What this trial is testing

Study of NeisVac-C Vaccine to Evaluate Immunological Interference With Hepatitis B, Inactivated Polio and Acellular Pertussis Vaccines in Healthy Infants

Who this might be right for
Meningitis, Meningococcal
Pfizer 330
Post-approval studies (Phase 4)Looking for participantsNCT06113198
What this trial is testing

A Study on the Immune Response and Safety of a Vaccine Against N. Meningitidis Serogroup B Infection in Healthy Infants From 2 Months of Age

Who this might be right for
Meningitis, Meningococcal
GlaxoSmithKline 50
Testing effectiveness (Phase 2)Study completedNCT01461980
What this trial is testing

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Who this might be right for
VaccinesMeningococcal Vaccines
Pfizer 2,648
Testing effectiveness (Phase 2)Study completedNCT00134719
What this trial is testing

Hib-MenCY-TT Vaccine Study Compared to Licensed Hib and Meningococcal Serogroup C Conjugate Vaccines

Who this might be right for
Neisseria MeningitidisHaemophilus Influenzae Type b
GlaxoSmithKline 1,104
Post-approval studies (Phase 4)Study completedNCT02569632
What this trial is testing

Investigating the Immunogenicity of a U.S.-Licensed Meningococcal Serogroup B Vaccine (Trumenba)

Who this might be right for
Meningococcal Infections
UCSF Benioff Children's Hospital Oakland 18
Large-scale testing (Phase 3)Study completedNCT00661713
What this trial is testing

Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine Administered to Healthy Adolescents According to Different Vaccination Schedules

Who this might be right for
Meningococcal Disease
Novartis Vaccines 1,631
Large-scale testing (Phase 3)Study completedNCT00891176
What this trial is testing

Persistence of Antibodies at 3, 4 and 6 Years of Age After Vaccination With Meningococcal, Pneumococcal and Hib Vaccines

Who this might be right for
Neisseria MeningitidisHaemophilus Influenzae Type b
GlaxoSmithKline 582
Not applicableStudy completedNCT00161941
What this trial is testing

Follow-up Study on the Antibody Response to Hepatitis B, Acellular Pertussis Toxin and Inactivated Poliovirus Antigens 1 Month After the 4th Hexavac® Vaccination in Healthy Children, Who Participated in NeisVac-C Study 216

Who this might be right for
Meningococcal Meninigitis, Serogroup C
Pfizer 321
Large-scale testing (Phase 3)Study completedNCT00136604
What this trial is testing

Response to GSK Biologicals' Tritanrix-HepB/Hib-MenAC Vacc (4th Dose) at 15-24m & Mencevax ACWY at 24-30m

Who this might be right for
Whole Cell PertussisHaemophilus Influenzae Type bHepatitis B+3 more
GlaxoSmithKline 617
Early research (Phase 1)Not Yet RecruitingNCT07395739
What this trial is testing

A Phase I Clinical Trial to Assess the Safety and Immunogenicity of DX-104

Who this might be right for
Neisseria Meningitidis Serogroup B
Shanghai Yuguan Biotech Co., Ltd.（Delonix Bioworks) 30
Large-scale testing (Phase 3)Study completedNCT00326118
What this trial is testing

Study in Toddlers to Demonstrate Non-inferiority of GSK Biologicals' Hib-MenC & to Evaluate Persistence up to 5 Years.

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 433
Testing effectiveness (Phase 2)Study completedNCT00291967
What this trial is testing

Assess Immune Response Following Primary Vaccination With Tritanrix™-HepB Vaccine Mixed With 3 Formulations of Hib-MenAC Vaccine to Infants

Who this might be right for
DiphtheriaTetanusPertussis+3 more
GlaxoSmithKline 525
Testing effectiveness (Phase 2)Study completedNCT00127855
What this trial is testing

Dose Ranging Study of Combined Haemophilus Influenzae Type B-Meningococcal Serogroups CY (Hib-MenCY-TT) Vaccine

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 409
Large-scale testing (Phase 3)Study completedNCT02305446
What this trial is testing

Safety and Blood Donations in Adults Vaccinated With rMenB+OMV NZ.

Who this might be right for
Meningitis, Meningococcal, Serogroup B
Novartis 55
Load More Results